Cargando…

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection

Mostrar otras versiones (1)

BACKGROUND: Covid-19 infection and cancer are associated with an increased risk of thrombotic events. The aim of our study is to analyze the cumulative incidence of thrombosis in oncological patients with Covid-19 and detect differences with the non-cancer Covid-19 population. METHODS: We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obispo, Berta, Rogado, Jacobo, Muñoz-Rivas, Nuria, Pangua, Cristina, Serrano, Gloria, Lara, Miguel Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435048/ https://www.ncbi.nlm.nih.gov/pubmed/36065235 http://dx.doi.org/10.1016/j.medcle.2021.08.013

Ejemplares similares

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022)

COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors
por: Rogado, Jacobo, et al.
Publicado: (2021)

Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
por: Rogado, Jacobo, et al.
Publicado: (2021)

Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Covid-19 and lung cancer: A greater fatality rate?
por: Rogado, Jacobo, et al.
Publicado: (2020)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic()
por: Rogado, Jacobo, et al.
Publicado: (2020)

Características y evolución de los pacientes con cáncer de pulmón e infección Covid-19 en un hospital de segundo nivel durante los 3 primeros meses de pandemia
por: Rogado, Jacobo, et al.
Publicado: (2020)

The Other Cost of the Pandemic
por: Obispo, Berta, et al.
Publicado: (2022)

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
por: Rogado, J., et al.
Publicado: (2020)

1766P COVID-19 and lung cancer: What do we know?
por: Serrano, G., et al.
Publicado: (2020)

1771P Do breast cancer patients with COVID-19 have a poor prognosis? Experience in a hospital in Madrid
por: Obispo, B., et al.
Publicado: (2020)

1685P Is cancer what determines COVID-19 oncological patient’s outcome or are other external factors involved? Experience in a hospital in Madrid, Spain
por: Rogado, J., et al.
Publicado: (2020)

New perspectives in the management of small cell lung cancer
por: Pangua, Cristina, et al.
Publicado: (2022)

1573P First wave mortality data versus full pandemic period from the COVID-CANCER HUIL study
por: Serrano-Montero, G., et al.
Publicado: (2021)

1576P COVID-CANCER HUIL - Registry of oncological patients with diagnosis of COVID-19 at Hospital Universitario Infanta Leonor in Madrid (Spain): One year of pandemic
por: Rogado, J., et al.
Publicado: (2021)

Superior mesenteric vein thrombosis as the only manifestation of SARS-CoV-2 infection()
por: Navarro-Martínez, Sergio, et al.
Publicado: (2022)

Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection
por: Franco-Moreno, Anabel, et al.
Publicado: (2023)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
por: Siddiqi, Hasan K., et al.
Publicado: (2021)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
por: Galán-Huerta, Kame A., et al.
Publicado: (2022)

First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission
por: Sola Campoy, Pedro J., et al.
Publicado: (2022)

First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission
por: Sola Campoy, Pedro J., et al.
Publicado: (2022)

Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay
por: Hong, Ki Ho, et al.
Publicado: (2022)

Role of Hologic® Panther Aptima™ SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?
por: García-Salguero, Cristina, et al.
Publicado: (2023)

SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome()
por: de Cortina Camarero, Cristina, et al.
Publicado: (2021)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

Getting to the (germinal) centre of SARS-CoV-2
por: Richter, Felix Clemens, et al.
Publicado: (2020)

SARS-CoV-2 detection goes mobile
por: Clyde, Dorothy
Publicado: (2020)

Mapping host restriction of SARS-CoV-2
por: Gea-Mallorquí, Ester
Publicado: (2020)

Searching for relatives of SARS-CoV-2 in bats
por: York, Ashley
Publicado: (2021)

SARS-CoV-2 ‘super-permissive’ cells
por: Hofer, Ursula
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b6ve6jap309kopkadg9c59ach1